1. Home
  2. CVRX vs NATH Comparison

CVRX vs NATH Comparison

Compare CVRX & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • NATH
  • Stock Information
  • Founded
  • CVRX 2000
  • NATH 1916
  • Country
  • CVRX United States
  • NATH United States
  • Employees
  • CVRX N/A
  • NATH N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NATH Restaurants
  • Sector
  • CVRX Health Care
  • NATH Consumer Discretionary
  • Exchange
  • CVRX Nasdaq
  • NATH Nasdaq
  • Market Cap
  • CVRX 419.8M
  • NATH 385.4M
  • IPO Year
  • CVRX 2021
  • NATH N/A
  • Fundamental
  • Price
  • CVRX $6.25
  • NATH $93.98
  • Analyst Decision
  • CVRX Strong Buy
  • NATH
  • Analyst Count
  • CVRX 7
  • NATH 0
  • Target Price
  • CVRX $16.83
  • NATH N/A
  • AVG Volume (30 Days)
  • CVRX 516.2K
  • NATH 11.0K
  • Earning Date
  • CVRX 05-08-2025
  • NATH 06-11-2025
  • Dividend Yield
  • CVRX N/A
  • NATH 2.15%
  • EPS Growth
  • CVRX N/A
  • NATH 24.88
  • EPS
  • CVRX N/A
  • NATH 5.80
  • Revenue
  • CVRX $51,292,000.00
  • NATH $146,386,000.00
  • Revenue This Year
  • CVRX $22.17
  • NATH N/A
  • Revenue Next Year
  • CVRX $24.02
  • NATH N/A
  • P/E Ratio
  • CVRX N/A
  • NATH $16.20
  • Revenue Growth
  • CVRX 30.53
  • NATH 6.83
  • 52 Week Low
  • CVRX $5.87
  • NATH $64.02
  • 52 Week High
  • CVRX $18.55
  • NATH $104.96
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 25.78
  • NATH 51.16
  • Support Level
  • CVRX $5.91
  • NATH $92.64
  • Resistance Level
  • CVRX $6.71
  • NATH $95.00
  • Average True Range (ATR)
  • CVRX 0.84
  • NATH 3.33
  • MACD
  • CVRX -0.43
  • NATH 0.06
  • Stochastic Oscillator
  • CVRX 5.28
  • NATH 66.44

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: